Bio-Techne Corporation (TECH) Presents at Stifel 2025 Healthcare Conference Transcript
Bio-Techne Corporation ( TECH ) Stifel 2025 Healthcare Conference November 11, 2025 9:20 AM EST Company Participants Kim Kelderman - CEO, President & Director James Hippel - Executive VP of Finance & CFO Conference Call Participants Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Daniel Arias Stifel, Nicolaus & Company, Incorporated, Research Division Okay. We'll go ahead and get started.
Bio-Techne Corporation (TECH) Presents at UBS Global Healthcare Conference 2025 Transcript
Bio-Techne Corporation ( TECH ) UBS Global Healthcare Conference 2025 November 10, 2025 10:15 AM EST Company Participants Kim Kelderman - CEO, President & Director James Hippel - Executive VP of Finance & CFO Conference Call Participants Daniel Leonard - UBS Investment Bank, Research Division Presentation Daniel Leonard UBS Investment Bank, Research Division Our next session here is the management team from Bio-Techne. We're lucky to be joined by Kim Kelderman, Jim Hippel and Dave Clair.
Bio-Techne Corporation (TECH) Q1 2026 Earnings Call Transcript
Bio-Techne Corporation ( TECH ) Q1 2026 Earnings Call November 5, 2025 9:00 AM EST Company Participants David Clair - VP of Investor Relations & Corporate Development Kim Kelderman - CEO, President & Director James Hippel - Executive VP of Finance & CFO Conference Call Participants Daniel Leonard - UBS Investment Bank, Research Division Matthew Larew - William Blair & Company L.L.C., Research Division Puneet Souda - Leerink Partners LLC, Research Division Patrick Donnelly - Citigroup Inc., Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Kyle Boucher - TD Cowen, Research Division Catherine Ramsey - Robert W.
TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up
Bio-Techne's Q1 earnings meet expectations, but revenues slip 1%, sending shares lower despite stronger margins.
Here's What Key Metrics Tell Us About Techne (TECH) Q1 Earnings
While the top- and bottom-line numbers for Techne (TECH) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Techne (TECH) Meets Q1 Earnings Estimates
Techne (TECH) came out with quarterly earnings of $0.42 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.42 per share a year ago.
Techne (TECH) Reports Next Week: What to Know Ahead of the Release
Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bio-Techne Q1 Earnings Preview: What's in Store for the Stock?
TECH's Q1 results could reflect steady Protein Sciences growth but pressure in Spatial Biology amid NIH and biotech funding uncertainty.
Bio-Techne Corporation (TECH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Bio-Techne Corporation (NASDAQ:TECH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 10:45 AM EDT Company Participants James Hippel - Executive VP of Finance & CFO Presentation Unknown Analyst All right. Thank you, everyone, for joining today.
Bio-Techne Corporation (TECH) Presents At Baird Global Healthcare Conference 2025 Transcript
Bio-Techne Corporation (NASDAQ:TECH ) Baird Global Healthcare Conference 2025 September 9, 2025 9:05 AM EDT Company Participants James Hippel - Executive VP of Finance & CFO Conference Call Participants Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Presentation Catherine Ramsey Senior Research Analyst Catherine Schulte.
Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript
Bio-Techne Corporation (NASDAQ:TECH ) Q4 2025 Earnings Conference Call August 6, 2025 9:00 AM ET Company Participants David Clair - VP of Investor Relations & Corporate Development James T. Hippel - Executive VP of Finance & CFO Kim Kelderman - CEO, President & Director Conference Call Participants Brandon Couillard - Wells Fargo Securities, LLC, Research Division Daniel Markowitz - Evercore ISI Institutional Equities, Research Division Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Daniel Louis Leonard - UBS Investment Bank, Research Division Kyle Boucher - TD Cowen, Research Division Matthew Richard Larew - William Blair & Company L.L.C.
Here's What Key Metrics Tell Us About Techne (TECH) Q4 Earnings
The headline numbers for Techne (TECH) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
